| BRAF v600e | ||
| Title: | BRAF v600e | |
| URL: | http://www.clarientinc.com | |
| Category: | Health: Hospitals and Medical Centers | |
| Description: | The BRAF (V600E) mutation analysis is predictive for anti-EGFR therapies (i.e., cetuximab and panitumumab). BRAF mutations account for approximately 12-15% of colorectal cancer patients. | |
| ID: | 13952 | |